Simon Reif
University of Pretoria
14 Papers
150 Citations
Simon Reif is an academic researcher from University of Pretoria. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 7, co-authored 14 publications. Previous affiliations of Simon Reif include University of South Africa.
Chat about Author
Papers
Sclerotherapy for hydroceles.
TL;DR: Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles with an over-all cure rate of 96% and a post-sclerotherapy operation necessary in 4% of the patients.
102
Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study.
Eija Lundstrom,Rupert K. Rencken,Johann H. van Wyk,Lance J.E. Coetzee,Johann C.M. Bahlmann,Simon Reif,Erdam A. Strasheim,Martin C. Bigalke,Alan R. Pontin,Louis Goedhals,Douw G. Steyn,Chris F. Heyns,Luigi A. Aldera,Thomas M. Mackenzie,Daniela Purcea,Pierre Grosgurin,Hervé Porchet +16 more
TL;DR: The triptorelin 6-month formulation was well tolerated and was able to achieve and maintain castration for the treatment of locally advanced and metastatic prostate cancer by reducing the frequency of required injections.
54
Biochemical analysis of tunica vaginalis fluid in patients with or without idiopathic hydroceles
TL;DR: Differences in the biochemical content of the fluid was compared with that of the tunica vaginalis fluid from a small group of controls taken from patients undergoing orchidectomy for carcinoma of the prostate, and whether these differences have a role in the causation of an idiopathic hydrocele is speculative.
11
Comparative trial of sclerotherapy for hydroceles
TL;DR: Tetradecyl sulphate and rolitetracycline were found to be equally effective as sclerosants and there were no statistically significant differences between the 2 drugs in respect of cure rate and complications.
10
Melatonin and steroid-dependent carcinomas.
TL;DR: From the results, it would seem that low melatonin levels could possibly play a role in breast carcinoma, but the same did not necessarily applied to prostatic cancer.
8